Effects of Alendronate and Raloxifene on Bone Density and Bone Turnover Markers in Postmenopausal Women

Effects of Alendronate and Raloxifene on Bone Density and Bone Turnover Markers in Postmenopausal Women

OBJECTIVE: The aim of this study was to compare the effects of once weekly alendronate sodium (ALN) and daily raloxifene hydrochloride (RLX) treatment on bone mineral density (BMD) and bone turnover markers in postmenopausal osteoporotic women. STUDY DESIGN: We included 343 postmenopausal women with...

Full description

Bibliographic Details
Main Authors: Ebru Zülfikaroğlu, Sevtap Kılıç, Süleyman Eserdağ, Sertaç Batıoğlu
Format: Article
Language:English
Published: Medical Network 2011-04-01
Series:Gynecology Obstetrics & Reproductive Medicine
Subjects:
Alendronate, Raloxifene, BMD, Bone turnover markers, Tolerability, Osteoporosis
Online Access:http://gorm.com.tr/index.php/GORM/article/view/284

Internet

http://gorm.com.tr/index.php/GORM/article/view/284

Similar Items